Abiopharma

Clinical trial NCT05111015 updates: 1. start date: 2013-02-01 → 2024-03-11 2. completion date: 2030-01-01 → 2040-01-01 3. primary completion date: 2030-01-01 → 2040-01-01

Clinical trial NCT05880576 updates: 1. completion date: 2025-06-30 → 2026-12-30 2. primary completion date: 2025-06-01 → 2026-12-01

Clinical trial NCT05117086: primary completion date: 2026-06-11 → 2026-12-01.

Clinical trial NCT03198650 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2025-09-25

Clinical trial NCT05091567: completion date: 2026-08-13 → 2028-02-28.

Clinical trial NCT06970106 updates: 1. completion date: 2028-01-01 → 2029-11-01 2. primary completion date: 2027-12-01 → 2029-10-01 3. enrollment: 18 → 24 participants

Clinical trial NCT05128955 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-01 → 2026-04-22 3. primary completion date: 2026-12-01 → 2026-04-22 4. enrollment: 250 → 180 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07554469 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-05-26

Clinical trial NCT07624071 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-06-04

Clinical trial NCT07480356 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-29